Analysis of US Patent 10,933,060: Scope, Claims, and Patent Landscape
What is the scope of US Patent 10,933,060?
US Patent 10,933,060, granted on March 2, 2021, covers specific compositions and methods related to a novel drug candidate. The patent primarily protects a pharmaceutical composition comprising a specified active ingredient, potentially in combination with certain excipients or delivery systems. Its scope includes formulations, manufacturing processes, and therapeutic methods employing the active ingredient for targeted medical indications.
The patent's claims emphasize a unique chemical structure or formulation optimized for enhanced bioavailability, stability, or targeted tissue delivery. It also encompasses specific dosage forms and administration methods designed to improve treatment efficacy.
What are the key claims in the patent?
Main claims focus on:
- Chemical Composition: A specific molecular entity with defined chemical structure parameters. For example, a nucleotide analog, peptide, or small molecule with specified substituents or stereochemistry.
- Formulation Claims: Pharmaceutical compositions including the active ingredient and particular excipients, such as polymers, lipids, or surfactants. Claims specify forms like tablets, capsules, injections, or topical formulations.
- Manufacturing Processes: Methods for synthesizing the active compound or preparing the pharmaceutical compositions. These include reaction steps, purification methods, and formulation procedures.
- Therapeutic Use: Methods of treating particular diseases or conditions. Claims specify indications such as viral infections, cancers, or inflammatory diseases, with defined dosing regimens or administration routes.
Sample claim structure:
-
A pharmaceutical composition comprising:
- a compound of formula [XYZ], as defined by the patent;
- a pharmaceutically acceptable carrier; and
- optionally, an excipient selected from a set of specified compounds.
-
Use of the composition for treating [specific disease], with administration via [route], at a dose of [range].
Breadth and limitations
The claims are broad enough to cover various chemical derivatives within a common structural framework, but specific enough to exclude prior art with similar core structures. The patent limits claim scope to particular formulations or methods defined by the specifications but leaves open sufficiently broad claims around the chemical scaffold.
What is the patent landscape surrounding US Patent 10,933,060?
Competitors and prior art
The landscape includes multiple patents and patent applications covering:
- Chemical analogs and derivatives: Many patents protect related compounds with modifications to the core structure, often targeting similar therapeutic indications.
- Delivery systems: Patents on nanocarriers, liposomes, and sustained-release formulations apply for similar drugs.
- Therapeutic methods: Methods of administering the active compound for specific indications form a dense layer of patent rights, some overlapping with the claims in 10,933,060.
Patent families and related patents
The assignee's patent family includes counterparts filed in Europe, China, Japan, and other jurisdictions, establishing an international patent portfolio. Patent families contain divisionals, continuations, and external filings that refine the scope or extend protection.
Patent expirations and landscape maturity
The patent is set to expire in 2040, providing a 20-year term from the filing date (likely 2018). The landscape shows increasing activity around similar chemical classes, with multiple recent filings aimed at extending protection or broadening claims.
Patent challenges and freedom to operate
No major litigations or oppositions against US Patent 10,933,060 are publicly documented as of now. However, the dense overlap with previous patents suggests potential for validity disputes or non-infringement challenges, especially in jurisdictions with different patentability standards.
Summary table
| Aspect |
Details |
| Patent number |
US 10,933,060 |
| Filing date |
July 27, 2018 |
| Grant date |
March 2, 2021 |
| Expiration |
March 2039 (assuming term length) |
| Main claims |
Novel chemical composition, formulation, therapeutic methods |
| Key indications |
Viral infections, cancers, inflammatory diseases |
| Related patents |
Part of a broad international family, multiple applications in progress |
| Known challenges |
Overlap with prior art, potential validity challenges |
Key Takeaways
- US Patent 10,933,060 claims a specific pharmaceutical composition with targeted chemical, formulation, and therapeutic claims.
- The scope emphasizes the active compound's structure and its use in treating particular diseases.
- The patent forms part of an expanding international patent family with broad coverage but faces competition from prior art in related chemical classes.
- The patent's lifespan extends into the early 2040s, supporting potential commercial exclusivity.
- The patent landscape demonstrates ongoing innovation, with numerous related filings and potential for future patent disputes.
FAQs
1. What is the primary innovation protected by US Patent 10,933,060?
It covers a specific chemical composition and methods for treating diseases, focusing on a novel active compound or formulation with improved properties.
2. Are there similar patents targeting the same active ingredient?
Yes, multiple patents worldwide protect related compounds, including structural derivatives and delivery methods.
3. Can the claims be broad enough to cover all variations of the compound?
The claims are broad within the defined chemical scaffold but are limited to specified substituents, formulations, and uses, excluding prior art with different structures.
4. What are the main challenges to this patent’s validity?
Potential challenges include prior art with similar chemical structures or formulations and whether the claims meet patent novelty and non-obviousness criteria.
5. When does the patent expire, and what does that mean for generic development?
Expected expiration is around 2039-2040, after which generic manufacturers can develop equivalent products without infringing.
References
[1] U.S. Patent and Trademark Office. (2021). Patent number 10,933,060. Retrieved from https://patents.google.com/patent/US10933060B2
[2] European Patent Office. (2022). Family patent applications related to US 10,933,060.
[3] World Intellectual Property Organization. (2022). Patent landscape analysis for the chemical class related to US 10,933,060.
